Jingjing Wu
Jiangnan University(CN)Xuzhou Medical College(CN)Capital Medical University(CN)Utrecht University(NL)China Rehabilitation Research Center(CN)Zhengzhou University(CN)Xian Center for Disease Control and Prevention(CN)Huaian First People’s Hospital(CN)Shanghai Changzheng Hospital(CN)Education Department of Fujian Province(CN)Wuxi Fourth People's Hospital(CN)Chinese Institute for Brain Research(CN)Second People’s Hospital of Huai’an(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Fujian Provincial Hospital(CN)Jiangsu Province Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)Second Affiliated Hospital of Zhejiang University(CN)Beijing Obstetrics and Gynecology Hospital(CN)Shanghai Ocean University(CN)Shaanxi University of Science and Technology(CN)Southern Medical University(CN)Beijing University of Civil Engineering and Architecture(CN)Nanjing Medical University(CN)Tsinghua University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Acute Ischemic Stroke Management, Immune Cell Function and Interaction, Viral-associated cancers and disorders, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Heart Failure With Preserved Ejection Fraction and Diabetes(2019)325 cited
- → RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer(2018)246 cited
- → Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma(2018)195 cited
- → Metabolic syndrome in menopause and associated factors: a meta-analysis(2017)160 cited
- → Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance(2018)145 cited
- → DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China(2016)139 cited